510(k) · Cleared
ClearedTricos T
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Baxter Healthcare Corp · MQV Filler, Bone Void, Calcium Compound
Cleared on Nov 18, 2005 as substantially equivalent to K032268 (Biomatlante, 2003) and 4 other predicates after a 144-day review. Its family tree reaches back 3 generations to 1999. 3 later devices descend from it.
- Decided
- Nov 18, 2005
- Review
- 144 days
- Class
- Class II
- Product code
- MQV
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 3 generations to K990131 (1999). 10 ancestors in all. 3 later devices descend from it, 3 citing it directly.
- Root · 3 generations backK990131 Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl. · 1999
- 2 generations backK020986 Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc. · 2002
- 1 generation backK032268 MBCPBiomatlante · 2003
- This deviceK051722 Tricos TBaxter Healthcare Corp · 2005
- Descendant · cites it directly · 2 of its ownK073571 Tricos T Resorbable Bone SubstituteBaxter Healthcare Corporation · 2008
- Descendant · cites it directly · 0 of its ownK081717 Tricos a Resorbable Bone SubstituteBaxter Healthcare Corp · 2008
- Descendant · cites it directly · 0 of its ownK081721 Tricos a Resorbable SubstituteBaxter Healthcare Corp · 2008
Most influential descendants
Showing 3 of 3 · See all- K073571Tricos T Resorbable Bone SubstituteBaxter Healthcare Corporation · 2008 · cites it directly2descendants
- K081717Tricos a Resorbable Bone SubstituteBaxter Healthcare Corp · 2008 · cites it directly0descendants
- K081721Tricos a Resorbable SubstituteBaxter Healthcare Corp · 2008 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K990131 | Pro Osteon Implant 500R Resorbable Bone Graft Substitute | Interpore Cross Intl. | 1999 | — |
| −2 | K020986 | Mastergraft Resorbable Ceramic | Medtronic Sofamor Danek, Inc. | 2002 | — |
| −1 | K032268 | MBCP | Biomatlante | 2003 | — |
| 0 (this device) | K051722 | Tricos T | Baxter Healthcare Corp | 2005 | — |
| +1 | K073571 | Tricos T Resorbable Bone Substitute | Baxter Healthcare Corporation | 2008 | — |
| +1 | K081717 | Tricos a Resorbable Bone Substitute | Baxter Healthcare Corp | 2008 | — |
| +1 | K081721 | Tricos a Resorbable Substitute | Baxter Healthcare Corp | 2008 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2003 | 2 | 0 |
| 2004 | 3 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MQV device
- #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K032268 | MBCPSummary page 1…le Calcium Salt Bone Void Filler (21 CFR Name: §888.3045) Predicate Device: MBCP BIOMATLANTE 5 10(k) K032268 Collagraft Strip Bone Graft Matrix NeuColl, Inc. 5 10(k) K0… | 2003 |
| * | K000122 | Collagraft Strip Bone Graft Matrix (for Use as a Bone Filler), Model 1X,3X,6X (1,3 or 6…Summary page 1…NTE 5 10(k) K032268 Collagraft Strip Bone Graft Matrix NeuColl, Inc. 5 10(k) K000 122 Allomatrix Putty Wright Medical Technology, Inc. 5 10(k) K0… | 2001 |
| * | K020895 | Allomatrix Model# 86Summary page 1…c. 5 10(k) K000 122 Allomatrix Putty Wright Medical Technology, Inc. 5 10(k) K020895 TCP Putty Stryker Biotech 5 10(k) K041421… | 2004 |
| * | K041421 | Name Bone Void FillerSummary page 1…t Medical Technology, Inc. 5 10(k) K020895 TCP Putty Stryker Biotech 5 10(k) K041421 JAX-tcp Smith & Nephew, Inc. 510(k) K033552 Description of th… | 2004 |
| * | K033552 | Jax-TCPSummary page 1…Stryker Biotech 5 10(k) K041421 JAX-tcp Smith & Nephew, Inc. 510(k) K033552 Description of the Device: TricOs T is a resorbable bone substitute that is replaced over time by newly formed bone. TricOs T co… | 2004 |
What descends from it? (3)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 6 years and passes through 4 companies; a new generation was cleared every 1.9 years on median.
- 2 of the 10 ancestors have a recall of any class.
- Of its descendants, K073571 (Baxter Healthcare Corporation, 2008) has gone furthest, with 2 descendants of its own.
- 10 other devices also cite its predicate K032268.
How does its category compare?
All MQV devicesMQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MQV
14in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MQV
57in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MQV
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MQV
57in 2025
MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 35 | 144 | 5 | 67 |
| 2008 | 32 | 102 | 3 | 71 |
| 2009 | 23 | 180 | 1 | 81 |
| 2010 | 17 | 147 | 0 | 68 |
| 2011 | 16 | 92 | 6 | 114 |
| 2012 | 9 | 107 | 3 | 149 |
| 2013 | 12 | 197 | 2 | 223 |
| 2014 | 20 | 153 | 0 | 111 |
| 2015 | 18 | 184 | 0 | 125 |
| 2016 | 8 | 214 | 1 | 106 |
| 2017 | 17 | 124 | 1 | 107 |
| 2018 | 23 | 124 | 2 | 86 |
| 2019 | 13 | 90 | 0 | 65 |
| 2020 | 15 | 132 | 1 | 126 |
| 2021 | 8 | 88 | 0 | 101 |
| 2022 | 9 | 118 | 0 | 47 |
| 2023 | 21 | 74 | 3 | 120 |
| 2024 | 28 | 55 | 2 | 68 |
| 2025 | 14 | 57 | 1 | 57 |
| 2026 | 5 | 96 | 4 | — |
What is it indicated for?
TricOs T is indicated for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. It is indicated for surgically created osseous defects or osseous defects resulting from traumatic injury. TricOs T is a bone void filler without initial mechanical properties, therefore rigid fixation techniques may often be recommended. TricOs T is intended to be packed into bony voids or gaps of the skeletal system (i.e.…
Read the full statement (118 words)
TricOs T is indicated for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. It is indicated for surgically created osseous defects or osseous defects resulting from traumatic injury. TricOs T is a bone void filler without initial mechanical properties, therefore rigid fixation techniques may often be recommended.
TricOs T is intended to be packed into bony voids or gaps of the skeletal system (i.e. the extremities, spine, and pelvis). Following placement in the bony void or gap, TricOs T is resorbed and replaced with bone during the healing process.
Fibrin matrix without the HAfIACP granules is not indicated for use as a bone void filler.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K051722 · printed Nov 6, 2026
Cite this page
510(k) Report. “K051722: Tricos T.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051722
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026